• ABOUT
  • ENTREPRENEURS
  • INVESTORS
  • 2024 CALENDAR
  • PORTFOLIO
  • MEMBER PLAYBOOK
  • MASHUP

New Capital MASHUP24

Tough Topics Tiny Tables

with OG investors & experts

Intimate longform dialogue with investor and expert OGs

5 founder seats per Tiny Table

Free for founders with a PreMASH ticket

ONLY 5 openings per topic - 1st come

Choose from Tough Topics

12:20 PM check-in

Team Due Diligence Ready: Mitigating Talent and Culture Risk
Ai Raise & Revenue Growth Hacks
Life Sciences investment value proposition Pre-seed to Series B
Executing on BIG Life Sciences Vision - having a platform AND investor coveted focus
Bench to pre-revenue investment - The Phd Founder
 
3:05 PM check-in
Qualifying & landing a lead VC
Investment deal smashing red flags checklists
Non dilutive funding value proposition
investor friendly deal terms + valuation
Building investor confidence with a strong projection narrative
Immigrant founder investment tips
 
 
 
 

Founders - preparing for your tttt session

  • bring your best questions
  • dont forget to have a succinct intro
  • follow up  - get the next meeting/ intros

AI Raise & Revenue

Growth Hacks

Devashish Paul

Founder & CEO

Bluwave.ai

BluWave-ai, a Capital Angel Network portfolio company, is optimizing renewable energy usage with Artificial Intelligence on Smart Grid IOT sensors. Dev is raising Series B with this sights on an IPO in the near future.

LinkedIn

Rade Kovacevic

Founding Partner

The Greater Return

Greater Return is a privately-held, mission-oriented investment company. We target early-stage entrepreneurs and companies that have identified a next generation regulatory market or societal change and are positioned to seize that opportunity and disrupt the status quo

Qualifying & landing a lead VC

Stéphane Caron

Partner

AQC Capital

Experienced VC and CFO in tech companies over the last 30 years. Fund manager in the pre-seed and seed space with a track record of funding companies in multiple rounds of financing.

Mathieu Gibeault

Cofounder, Managing Director Ventured Synergy

Passionate about building and launching new companies, Mathieu is actively involved in the Ottawa startup community.

Mathieu sits on multiple boards and is Managing Director at Ventured Synergy, a private investment firm focused on early-stage companies.

Mathieu has a strong inclination for startups with deep technology roots but also works with any exceptional team with disruptive business models, regardless of the industry.

 

Eliminating investment

deal smashing red flags

Brian O'Higgins

Experienced entrepreneur as the co-founder and CTO of Entrust, and co-founder and CTO of Third Brigade. Staying retired now, and enjoying Angel investing and serving on corporate boards and advisory boards.

Megan Cornell

Partner & Ottawa Corporate Group Lead

Dentons LLP

I’m a partner in Dentons’ Ottawa office, a member of the Firm's Corporate and Venture Technology & Emerging Growth Companies groups and the Corporate Group Lead. I specialize in advising investors and startups and helping companies with relationships and exits.

The evolving life sciences investor value proposition from Pre-seed to Series B

Ella Korets-Smith

Co-founder and Chief Strategy Officer

Vrica Biotech

Ms. Korets-Smith is an entrepreneur and biotechnology executive with extensive experience building and funding companies. She is co-founder of Virica Biotech, a revenue generating Series B funded company and Virano Therapeutics, an early stage innovative biotech, both in the cell and gene therapy space. Ella is also founder of EKS Business Development, an advisory firm creating value for founders and innovators through strategic partnerships and transactions.

Dane Bedward

CEONeuroBot Inc

Mr. Dane Bedward is the CEO of NeuroBot Inc., a strategic advisory company focused on assisting Medtech, Digital Medicine and Biopharma companies with their business strategies.

Prior to founding his advisory company, Dane was Senior Vice President International for Genzyme Corporation, one of the top 5 global biotech companies before being acquired by Sanofi-Aventis. His first assignment with Genzyme was as Managing Director and President of the Canadian subsidiary Genzyme Canada Inc. Genzyme Corporation is a pioneer in the development of products for rare genetic diseases.

Throughout his career Mr. Bedward has also worked with other organizations such as Nordion International, Johnson and Johnson (in Canada and Europe), Flow Laboratories, and McMaster University. Dane serves on the Board of Directors of The National Angel Capital Organization (NACO) and Panthera Cryosolutions, as well as chairs the Board of Directors for Spiderwort Inc.

He is also a member of the L-Spark MedTech Advisory Committee, an Executive Fellow with Mistral Venture Partners, a Steering Committee member for Alacrity Ottawa, a medical markets strategic advisor for Welch Capital Markets, and a Charter Member of TiE.

Dane has previously served on the following Boards: the Board of Directors of The Capital Angel Network (CAN), the Board of Governors of the University of Ottawa, the Board of Trustees for Bridgewater State University, The National Medical Devices Alliance, The Ottawa Health and Life Sciences Cluster, The New England-Canada Business Council, The Boston Philharmonic Orchestra, The New England-Latin America Business Council, The Ottawa Life Sciences Council, and the Board of Directors fo

Having it all - life sciences platform vision and investor coveted focus

julia pomoransky (rintoul)

Founder and Managing Director

Capital BioVentures

Capital BioVentures is an Accelerator Program that removes hurdles for our Canadian innovators, while fostering a collaborative and cohesive ecosystem in the National Capital Region. The program brings together lab space, seasoned biotech expertise, and funding to help our biotech firms scale.

LinkedIn

Charles M. Cuerrier

CEO

Spiderwort Inc.

Dr. Charles M. Cuerrier is the CEO and co-founder of Spiderwort Inc. He has been leading the company since its incorporation in 2015 and has raised a total of $20M CAD to date. He holds a Ph.D. in pharmacology and a postdoctoral training in regenerative medicine.

Investor confidence inspiring projections & narrative essentials - know your numbers

Marisa Fosco

Principle

Ametrine 360 & Investor

LinkedIn

Susan Richards

Co-founder & Managing Partner

numbercrunch

Susan Richards, FCPA, FCMA is an entrepreneurial accountant with 20 years of financial leadership experience in the Ottawa tech sector. Over the past 20 years Susan has served as CFO and/or Financial Advisor to over 50 start-ups.

An entrepreneur at heart, Susan is co-founder of Numbercrunch which provides outsourced financial services to startups and scaling businesses.

Susan’s previous companies included co-founding online marketplace, Givolopy.com, which was sold in 2018.

Susan is a community champion having recently served on the Boards of Invest Ottawa, Bayview Yards and Kanata North Business Association.  

LinkedIn

Team due diligence ready -

talent and culture risk mitigation

Jennifer Mondoux

CEO and Managing Partner

MondouxRollins Partners Inc

Jennifer is a human capital advisor and talent solutions professional, with nearly two decades’ worth of experience working with private companies. An exceptional search professional, she has helped dozens of founders and entrepreneurs of mid-market companies build out their senior leadership teams.

Jennifer is seen as a trusted advisor, with an expertise that allows her to guide clients through the lifecycle of their talent needs. This includes compensation design, performance management, market mapping, as well as other more highly specialized services in M&A talent mapping and executive communications.

In addition to her deep relationship with her entrepreneurial clients, Jennifer is connected both regionally and nationally with senior leadership candidates as well as with a network of professionals in private company leadership and governance.She is also the founder of Canada’s Best Private Boards, a first-of-its-kind national and annual program that recognizes the impact of governance on the performance of private companies.

LinkedIn

Alternative non dilutive funding -  winning value propositions for grants, gov funds and tax credits

Jashua Smith

Partner at Welch LLP

Accountant focused on maximizing company cash flow with quality tax advice and creative solutions.

Specialties: SR&ED (Scientific Research and Experimental Development Tax Credits). OIDMTC (Ontario Interactive Digital Media Tax Credits). Government and other funding sources (OCE, IRAP).Tax planning for individuals, trusts and corporations.

LinkedIn

Emille Rodrigues

Business Development and Commercialization Manager

In my role at OCI, I am always happy to support early-stage startups from the Ottawa region through connections or OCI's seed/pre-seed funds. CAN has always been a great ally and champion for the Ottawa region founders, so I am thrilled to collaborate with you in this community!

LinkedIn

Investor friendly deal terms & valuations for 2025

Sean Del Giallo

Partner

Dentons Canada LLP

Sean's practice focuses primarily on corporate law, financings and mergers and acquisitions in the technology sector. I regularly advise high growth emerging technology companies, venture capital funds, investors and founders on corporate governance, venture capital transactions, private placements and other business law matters.

 

 

LinkedIn

Dr. Brian Whitestone

Investor Capital Angel Network

Dr. Brian Whitestone is a retired Oral/Maxillofacial surgeon.

Brian recently helped create the Tay River Medical Centre in Perth, Ontario which is a growing community of Physicians and related healthcare professionals serving this region.

He has also been active in the Capital Angel Network for over 6 years, having personally made over 15 investments in early stage companies, while serving on the Board of Realize Medical, a local Ottawa based medical imaging startup.

Brian loves to dive deeply into researching topics related to Angel investing and frequently presents 'The Art of Valuation' as it pertains to companies in their early stages.

I'm a text box. Double click me to edit the text or to change the way I look. You can change the font, size, color, and more.

LinkedIn

Bench to pre-revenue investment -

The Phd Founder

Nicholas Calvert

Co-founder & CEO  Yellowbird Diagnostics

PhD Candidate in Chemistry

Nicholas closed his pre-seed round for his pre-seed startup Yellowbird Diagnostics while continuing his Phd studies at uOttawa.

Yellowbird Diagnostics develops new medical imaging dyes to better visualize “invisible” markers of disease.

 

 

LinkedIn

Dr. Brian Whitestone

Investor Capital Angel Network

Dr. Brian Whitestone is a retired Oral/Maxillofacial surgeon.

Brian recently helped create the Tay River Medical Centre in Perth, Ontario which is a growing community of Physicians and related healthcare professionals serving this region.

He has also been active in the Capital Angel Network for over 6 years, having personally made over 15 investments in early stage companies, while serving on the Board of Realize Medical, a local Ottawa based medical imaging startup.

Brian loves to dive deeply into researching topics related to Angel investing and frequently presents 'The Art of Valuation' as it pertains to companies in their early stages.

I'm a text box. Double click me to edit the text or to change the way I look. You can change the font, size, color, and more.

LinkedIn

Immigrant founder investment tips from the lens of Maple Bridge Ventures

LinkedIn

Eric Agyemang, Founder & Managing Partner at Maple Bridge Ventures

Eric is the Founder & Managing Partner of Maple Bridge Ventures, an early-stage, digital solutions-focused VC firm that invests in and champions game-changing immigrant founders in Canada.